FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare

Free Newsletter

About | View Sample | Privacy

Survey: Pharma not a good info source

Tools

Remember last month when Merck CEO Dick Clark remarked on Big Pharma's "trust deficit?" Well, here's quantitative evidence of it. A European Commission study found that healthcare professionals and payers are "mostly suspicious" of drugmakers as sources of information about drugs. Nearly half of the responders said pharma has too many conflicts of interest to be appropriate sources of general information on medications.

Some of the responses, however, indicated that if drug companies provided a clear distinction between ads and information, they could be valuable repositories because of their intimate knowledge of their products.

The opinions will be factored into decisions about a proposed code of conduct governing the release of info about pharmaceuticals in the E.U.

- see the item at Pharmalot
- check out the PharmaTimes story

Related Articles:
Pharma CEOs mull industry "trust deficit"
Survey: No doubt DTC ads work
10 reforms for drug advertising

Twitter   Facebook   LinkedIn   StumbleUpon  
Get Your FREE FiercePharma Email Newsletter:
Be the first to comment
More stories about DTC advertising   public trust   Trust Deficit   Richard Clark   Drug advertising  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

To combat spam, please enter the code in the image.